Clinical Trial

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Study acronym: IEIPAI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to systematically evaluate the dynamic alterations in peripheral immune subsets among patients with antibody Immunodeficiency undergoing Immunoglobulin therapy
Trial Details
NCT Number NCT07516002
Lead Sponsor Peking University People's Hospital
Conditions Primary Immunodeficiency Diseases
Enrollment 15 participants
Start Date 2026-04-01
Primary Completion 2029-10-01 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-07